Header cover image

Swedish (OMX) Life Sciences Industry Analysis

UpdatedAug 06, 2024
DataAggregated Company Financials
Companies12
  • 7D-6.5%
  • 3M18.9%
  • 1Y45.0%
  • YTD22.4%

Over the last 7 days, the Life Sciences industry has dropped 4.3%, driven by MedCap declining 8.1%. This takes the industry's 12 month performance to a gain of 48%. As for the next few years, earnings are expected to grow by 46% per annum.

Industry Valuation and Performance

Has the Swedish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 06 Aug 2024SEK 46.3bSEK 16.7b-SEK 1,128,120,510.0058.2x-41x2.8x
Thu, 04 Jul 2024SEK 42.2bSEK 16.3b-SEK 1,188,686,510.0054.2x-35.5x2.6x
Sat, 01 Jun 2024SEK 43.6bSEK 16.3b-SEK 1,188,686,510.0062.9x-36.7x2.7x
Mon, 29 Apr 2024SEK 37.7bSEK 16.2b-SEK 1,246,589,705.0036.2x-30.2x2.3x
Wed, 27 Mar 2024SEK 40.4bSEK 16.0b-SEK 1,122,792,210.0034.6x-36x2.5x
Fri, 23 Feb 2024SEK 39.3bSEK 16.0b-SEK 1,119,170,478.0043x-35.1x2.5x
Sun, 21 Jan 2024SEK 35.8bSEK 15.5b-SEK 1,393,723,683.0042.9x-25.7x2.3x
Tue, 19 Dec 2023SEK 38.2bSEK 15.5b-SEK 1,393,723,683.0045.3x-27.4x2.5x
Thu, 16 Nov 2023SEK 32.3bSEK 15.4b-SEK 1,256,647,710.0036.3x-25.7x2.1x
Sat, 14 Oct 2023SEK 24.0bSEK 15.1b-SEK 1,134,516,711.0033.5x-21.2x1.6x
Mon, 11 Sep 2023SEK 29.2bSEK 15.1b-SEK 1,133,713,072.0038.8x-25.8x1.9x
Wed, 09 Aug 2023SEK 31.8bSEK 15.1b-SEK 213,871,038.0045.7x-148.5x2.1x
Fri, 07 Jul 2023SEK 35.6bSEK 14.6b-SEK 172,476,038.0039x-206.2x2.4x
Sun, 04 Jun 2023SEK 40.0bSEK 14.6b-SEK 172,476,038.0039.5x-231.7x2.7x
Tue, 02 May 2023SEK 36.4bSEK 14.5b-SEK 138,425,792.0035x-262.9x2.5x
Thu, 30 Mar 2023SEK 32.3bSEK 14.6b-SEK 57,185,459.0032x-564.7x2.2x
Sat, 25 Feb 2023SEK 37.1bSEK 14.7b-SEK 44,319,199.0030.6x-838.2x2.5x
Mon, 23 Jan 2023SEK 38.7bSEK 14.2bSEK 943.9m38.1x41x2.7x
Wed, 21 Dec 2022SEK 38.0bSEK 14.1bSEK 944.3m40.4x40.3x2.7x
Fri, 18 Nov 2022SEK 37.4bSEK 14.2bSEK 944.1m40.6x39.6x2.6x
Sun, 16 Oct 2022SEK 33.3bSEK 13.5bSEK 750.9m50x44.4x2.5x
Tue, 13 Sep 2022SEK 39.3bSEK 13.5bSEK 751.3m56.5x52.3x2.9x
Thu, 11 Aug 2022SEK 44.9bSEK 13.2bSEK 667.8m46x67.3x3.4x
Sat, 09 Jul 2022SEK 48.0bSEK 13.2bSEK 753.4m42.1x63.8x3.6x
Mon, 06 Jun 2022SEK 55.5bSEK 13.2bSEK 753.4m48.3x73.7x4.2x
Wed, 04 May 2022SEK 52.2bSEK 12.8bSEK 744.1m47.3x70.2x4.1x
Fri, 01 Apr 2022SEK 64.3bSEK 11.8bSEK 746.3m56.6x86.1x5.4x
Sun, 27 Feb 2022SEK 53.9bSEK 11.9bSEK 745.3m44.8x72.3x4.5x
Tue, 25 Jan 2022SEK 62.1bSEK 10.8bSEK 786.3m41.8x79x5.8x
Thu, 23 Dec 2021SEK 85.6bSEK 10.8bSEK 786.3m58.5x108.9x7.9x
Sat, 20 Nov 2021SEK 89.2bSEK 10.8bSEK 788.5m55.6x113.1x8.3x
Mon, 18 Oct 2021SEK 93.3bSEK 9.9bSEK 853.6m54.6x109.3x9.5x
Wed, 15 Sep 2021SEK 99.6bSEK 9.9bSEK 853.6m58.5x116.7x10.1x
Fri, 13 Aug 2021SEK 91.6bSEK 9.9bSEK 853.6m49.3x107.3x9.3x
Price to Earnings Ratio

107.3x


Total Market Cap: SEK 91.6bTotal Earnings: SEK 853.6mTotal Revenue: SEK 9.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Life Sciences Industry Price to Earnings3Y Average -27.5x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 3.8x is higher than the industry's current PS ratio of 2.8x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 19% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-6.69%
Healthcare-6.08%
Life Sciences-6.47%
Clinical Research and Equipment-6.47%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CLINE B Cline ScientificSEK 0.0716.7%
+SEK 450.1k
-72.7%PS0.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GENO

SEK 27.25

Genovis AB (publ.)

7D

-6.7%

1Y

-39.7%

MAGLE

SEK 39.00

Magle Chemoswed Holding

7D

-7.1%

1Y

12.7%

MCAP

SEK 540.00

MedCap

7D

-9.2%

1Y

75.3%

AROC

SEK 0.49

AroCell

7D

-6.2%

1Y

-7.9%

BIOT

SEK 184.80

Biotage

7D

-5.2%

1Y

47.7%

BICO

SEK 38.72

BICO Group

7D

-9.6%

1Y

-10.3%

CLINE B

SEK 0.07

Cline Scientific

7D

16.7%

1Y

-72.7%

PRO

SEK 32.60

Promimic

7D

-15.1%

1Y

9.4%